Raw Juicery, Inc. – 598594 – 01/06/2022
Anonymous (not verified)
Fri, 01/14/2022 – 15:35
Company Name
Short Title
Raw Juicery, Inc.
Dear Mr. Davidson:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter #598594 dated June 11, 2020. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Darla R. Bracy
District Director | FDA San Francisco District
Program Division Director
Office of Human and Animal Food Operations – West Division 5
Fri, 01/14/2022 – 15:51
Review Date
Sat, 01/14/2023 – 00:00
Source Organization
Recipient Name
Mr. Ryan O. Davidson
Recipient Title
Owner and President
Content Owner
Last Reviewed Date
Fri, 01/14/2022 – 00:00
Site Structure
Letter Issue Date
January 06, 2022
Issuing Office Building Name
Division of Human and Animal Food Operations West V
Next Review Date
1 Year
Detailed Description
Juice HACCP/CGMP for Foods/Adulterated/Insanitary Conditions
Delivery Method
MARCS CMS ID
Bulk Approved
Off
Address
United States
Display Short Description
Off
Regulated Product*
Sender Address
United States
Recipient Address
915 Mateo St.
Ste 207
Los Angeles, CA 90021-1786
United States
Language
Address
United States
Associated for Closeout Letter
Add Subscription Box
Off
FDA – WEB CONTENT MANAGEMENT SYSTEM